We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+9.63%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$59.8B
AUM Growth
+$5.07B
(+9.3%)
Cap. Flow
+$518M
Cap. Flow
% of AUM
0.87%
Top 10 Holdings %
Top 10 Hldgs %
18.08%
Holding
2,992
New
38
Increased
2,358
Reduced
537
Closed
43
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$68M |
| 2 |
Truist Financial
TFC
|
+$55.9M |
| 3 |
ServiceNow
NOW
|
+$33.3M |
| 4 |
Uber
UBER
|
+$21.4M |
| 5 |
Las Vegas Sands
LVS
|
+$15.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$119M |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$55.9M |
| 3 |
Apple
AAPL
|
+$48.3M |
| 4 |
iShares TIPS Bond ETF
TIP
|
+$22M |
| 5 |
VIAB
Viacom Inc. Class B
VIAB
|
+$16.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.57% |
| 2 | Financials | 15.53% |
| 3 | Healthcare | 13.38% |
| 4 | Consumer Discretionary | 10.07% |
| 5 | Industrials | 9.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
First Industrial Realty Trust
FR
$8.69B
| $19.2M | 0.03% |
463,232
+13,988
| +3% | +$577K |
|
502
Maximus
MMS
$3.27B
| $19.2M | 0.03% |
258,415
-780
| -0.3% | -$58.6K |
|
|
PRAH
503
DELISTED
PRA Health Sciences, Inc.
PRAH
| $19.2M | 0.03% |
172,784
+1,205
| +0.7% | +$124K |
|
|
CZR
504
DELISTED
Caesars Entertainment Corporation
CZR
| $19.1M | 0.03% |
1,401,982
+76,943
| +6% | +$974K |
|
505
Raymond James Financial
RJF
$34.1B
| $19.1M | 0.03% |
319,427
+21,450
| +7% | +$1.24M |
|
506
Steel Dynamics
STLD
$36.7B
| $19.1M | 0.03% |
559,676
-20,645
| -4% | -$659K |
|
507
Five Below
FIVE
$11.9B
| $19M | 0.03% |
148,653
-931
| -0.6% | -$117K |
|
508
Owens Corning
OC
$11.5B
| $18.9M | 0.03% |
290,895
+8,327
| +3% | +$533K |
|
|
WRK
509
DELISTED
WestRock Company
WRK
| $18.9M | 0.03% |
441,182
+22,056
| +5% | +$860K |
|
|
SIVB
510
DELISTED
SVB Financial Group
SIVB
| $18.8M | 0.03% |
75,014
+1,118
| +2% | +$254K |
|
511
Ingredion
INGR
$6.3B
| $18.8M | 0.03% |
202,182
+1,912
| +1% | +$161K |
|
512
W.P. Carey
WPC
$16.5B
| $18.7M | 0.03% |
238,177
+15,707
| +7% | +$1.32M |
|
513
EastGroup Properties
EGP
$11.2B
| $18.5M | 0.03% |
139,530
+5,940
| +4% | +$780K |
|
514
Marvell Technology
MRVL
$173B
| $18.4M | 0.03% |
694,008
+46,837
| +7% | +$1.19M |
|
515
XPO
XPO
$23B
| $18.4M | 0.03% |
667,403
-11,485
| -2% | -$316K |
|
|
CMA
516
DELISTED
Comerica
CMA
| $18.4M | 0.03% |
256,225
+1,428
| +0.6% | +$98K |
|
517
Post Holdings
POST
$4.12B
| $18.4M | 0.03% |
257,129
-13,839
| -5% | -$947K |
|
518
Encompass Health
EHC
$11.2B
| $18.3M | 0.03% |
332,018
-9,109
| -3% | -$494K |
|
|
SBNY
519
DELISTED
Signature Bank
SBNY
| $18.3M | 0.03% |
133,689
-5,027
| -4% | -$629K |
|
520
Kohl's
KSS
$2.28B
| $18.2M | 0.03% |
357,678
+11,847
| +3% | +$602K |
|
|
CDK
521
DELISTED
CDK Global, Inc.
CDK
| $18.2M | 0.03% |
332,628
+3,866
| +1% | +$199K |
|
522
NRG Energy
NRG
$29.4B
| $18M | 0.03% |
452,028
+15,229
| +3% | +$602K |
|
|
DISCK
523
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
| $18M | 0.03% |
588,759
-5,517
| -0.9% | -$155K |
|
524
Sonoco
SON
$5.59B
| $17.9M | 0.03% |
290,139
+3,679
| +1% | +$218K |
|
525
Marriott Vacations Worldwide
VAC
$3.35B
| $17.9M | 0.03% |
138,664
+3,209
| +2% | +$376K |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2019 Portfolio in Review
As of Q4 2019, RhumbLine Advisers held 2,992 positions worth $59.8B, up 9.3% from $54.7B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Trading was light in Q4 2019: portfolio turnover was 2.7%. RhumbLine Advisers opened 38 new positions and exited 43, leaving the 2,992-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q4 2019 buy was Envista: 126,664 shares worth $3.75M.
- RhumbLine Advisers added most to Bristol-Myers Squibb in Q4 2019, an estimated $68M increase.
- RhumbLine Advisers's biggest Q4 2019 reduction was Apple, cutting an estimated $48.3M.
- RhumbLine Advisers fully exited Celgene Corp in Q4 2019, selling an estimated $119M.
- RhumbLine Advisers's ten largest holdings make up 18% of its $59.8B portfolio in Q4 2019.
- RhumbLine Advisers opened 38 new positions and closed 43 in Q4 2019.
- RhumbLine Advisers's portfolio value rose 9.3% quarter-over-quarter to $59.8B.
Based on RhumbLine Advisers's 13F filing for Q4 2019, filed 5 Feb 2020.